Autopsy report · NCT02785822

Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.

“Difficulties in recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 1 year 3 months before it stopped.
• 19 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Sponsor type

University, hospital or other

Conditions

Polycystic Ovary Syndrome

Interventions

hMG-HP; hFSH-HP

Participants

19

Sites

2

Countries

Spain

Trials that died the same way

• Alzheimer Disease : Rehabilitation's Intervention at Home
  “difficulties of recruitment” (99% match in meaning)
• Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) for Foreign-Born Arab Americans
  “Difficulties with recruitment” (98% match in meaning)
• Concordance Between Ultra-low Dose (ULD) and Standard Dose CT Scans in the Search for Traumatic Brain Injury
  “Recruitment difficulties” (98% match in meaning)
• SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer
  “difficulty in recruitment” (98% match in meaning)
• Robotic Decompression of the Pudendal Nerve in Pudendal Neuralgia
  “recruitments difficulties” (98% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.